Correspondence

Retina

Volumn 28, Issue 2, 2008, Pages 368-369

  Querques, Giuseppe ^a   Noci, Nicola Delle ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

CAPILLARY ENDOTHELIUM; CELL FUNCTION; DRUG EFFECT; FLUORESCENCE ANGIOGRAPHY; HUMAN; IDIOPATHIC JUXTAFOVEAL RETINAL TELANGIECTASIA; LETTER; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; POPULATION RESEARCH; RETINA DISEASE; TELANGIECTASIA;

EID: 43149088956     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31815ec3e3     Document Type: Letter

References (7)

1. Cohen SM, Cohen ML, El-Jabali F, Pautler SE. Optical coherence tomography findings in nonproliferative group 2a idiopathic juxtafoveal retinal telangiectasis. Retina 2007;27:59-66.
2. Schuman JS, Puliafito CA, Fujimoto JG. Optical Coherence Tomography of Ocular Diseases. 2nd ed. Thorofare, NJ: Slack, 2004;24:113-139, 140-147.
3. Gass JDM. Stereoscopic Atlas of Macular Disease, 4th ed. St. Louis, MO: Mosby, 1997;505-511.
4. Gass JDM. Histopathologic study of presumed parafoveal telangiectasis. Retina 2000;20:226-227.
5. Tout S, Chang-Ling T, Hollander H, Stone J. The role of Muller cells in the formation of the blood-retinal barrier. Neuroscience 1993;55:291-301.
6. Newman E, Reichenbach A. The Muller cell: a functional element of the retina. Trends Neurosci 1996;19:307-312.
7. Moon SJ, Berger AS, Tolentino MJ, Misch DM. Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis. Ophthalmic Surg Lasers Imaging 2007;38:164-166.